1200.0000 -5.00 (-0.41%)
NSE Apr 24, 2025 15:29 PM
Volume: 269.1K
 

Geojit BNP Paribas
The formulation business has registered a de-growth of 16% owing to the general slowness in the segment. With a strong order book and customer base in the CDMO segment , the company is poised to sustain its growth momentum in the long term....
Suven Pharmaceutical.. has an average target of 1402.50 from 2 brokers.
More from Suven Pharmaceuticals Ltd.
Recommended